Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy
scientific article
Author/s
author: Axel Le Cesne, Isabelle Ray-Coquard, Jean-Yves Blay, Mohammed Milhem, Nicolas Penel, Emmanuelle Bompas, George D Demetri, Peter Reichardt, Sant P Chawla, Arthur P Staddon, Thierry Alcindor
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.